BTS
LKFT

BB&T Securities’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BB&T Securities’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$402K Buy
2,664
+216
+9% +$35.4K ﹤0.01% 1191
2019
Q2 		$315K Sell
2,448
-141
-5% -$16.7K ﹤0.01% 1295
2019
Q1 		$304K Buy
+2,589
New +$261K ﹤0.01% 1282

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BB&T Securities's LKFT Position: Q3 2019 in Review

BB&T Securities increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 8.8% in Q3 2019, buying an estimated $35.4K and bringing the position to 2,664 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

BB&T Securities first reported a position in LKFT in Q1 2019 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold LKFT as of Q3 2019.

  • BB&T Securities held 2,664 shares of Lakefront Biotherapeutics American Depositary Shares worth $402K as of Q3 2019.
  • BB&T Securities bought 216 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2019, an estimated $35.4K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1191 holding.
  • BB&T Securities first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.